FDA Acts to Stem Misuse, Abuse of Antidiarrheal Loperamide FDA Acts to Stem Misuse, Abuse of Antidiarrheal Loperamide

The FDA moves to limit the number of loperamide doses per package amid ongoing reports of serious cardiac problems and deaths with misuse and abuse of the antidiarrhea medication.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news